How Much Omega-3 Should You Take? A Goal-by-Goal Guide

You've probably heard that omega-3s are good for you. But when you're standing in the supplement aisle staring at bottles listing EPA, DHA, and milligram counts that range from 300 to 3,000, the question becomes less about whether to take them and more about how much you actually need. The answer depends entirely on what you're trying to accomplish, because the dose that supports general health looks nothing like the dose used in clinical trials for heart disease or chronic inflammation.

The right omega-3 dose depends on your baseline status and your specific health goals. Superpower's baseline panel includes markers that reveal whether inflammation, lipid metabolism, or cardiovascular risk factors are driving your need for higher EPA and DHA intake.

Key Takeaways

• General health maintenance requires 250 to 500 mg combined EPA and DHA daily.
• Cardiovascular-focused omega-3 research in people with existing heart disease has generally used moderate to high daily doses of combined EPA and DHA.
• Anti-inflammatory effects require doses above 2,000 mg daily in most clinical trials (2023 meta-analysis).
• Cognitive function studies use 450 mg or more of combined EPA and DHA.
• Triglyceride reduction at prescription levels involves 2,000 to 4,000 mg of EPA daily.
• Vegan omega-3 from algae oil provides comparable bioavailability to fish oil.
• Higher doses do not automatically mean better outcomes without a clear clinical target.

What Omega-3s Actually Do and Why Dose Matters

Omega-3 fatty acids are polyunsaturated fats that your body cannot synthesize on its own. The two that matter most for human health are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

EPA is a 20-carbon fatty acid that serves as a precursor to signaling molecules called eicosanoids, which regulate inflammation, blood clotting, and vascular tone. DHA is a 22-carbon fatty acid that concentrates in cell membranes, particularly in the brain and retina, where it influences membrane fluidity, receptor function, and neuronal signaling. Omega-3s operate on a spectrum:

• At low intakes, they correct deficiency and support baseline cellular function.
• At moderate intakes, they shift the balance of inflammatory mediators in a way that may reduce chronic disease risk.
• At high intakes, they produce pharmacological effects that can lower triglycerides, reduce platelet aggregation, and modulate immune cell activity.

General Health Maintenance: The Baseline Dose

Most health organizations, including the American Heart Association and the European Food Safety Authority, recommend a minimum of 250 to 500 mg of combined EPA and DHA per day for adults without diagnosed cardiovascular disease. This range supports normal cell membrane function, reduces the risk of sudden cardiac death in healthy populations, and provides a modest anti-inflammatory effect.

This dose can be achieved through diet alone if you consume fatty fish two to three times per week. A 3-ounce serving of salmon provides roughly 1,500 mg of combined EPA and DHA. Sardines, mackerel, and anchovies are similarly rich sources. If you do not eat fish regularly, supplementation becomes the most reliable way to meet this baseline. For individuals following a plant-based diet, vegan omega-3 derived from algae oil provides comparable bioavailability to fish oil, with typical doses of 300 mg DHA and 150 mg EPA per serving.

Cardiovascular Protection: Doses for Heart Health

For people with existing coronary heart disease, such as those who have had a myocardial infarction, the American Heart Association recommends approximately 1,000 mg per day of combined EPA and DHA, preferably from oily fish, though supplements are considered acceptable under medical supervision (2018 meta-analysis).

The REDUCE-IT trial, which used 4,000 mg of purified EPA daily (icosapent ethyl), demonstrated a 25 percent reduction in major cardiovascular events in patients with elevated triglycerides and established cardiovascular disease or diabetes. This is a prescription-level dose, far higher than what is typically found in over-the-counter supplements. The mechanism involves:

• Triglyceride lowering through reduced hepatic VLDL synthesis.
• Stabilization of atherosclerotic plaques.
• Reduction of oxidative stress.
• Modulation of inflammatory pathways.

For primary prevention in individuals without diagnosed heart disease but with risk factors such as elevated apolipoprotein B or high-sensitivity C-reactive protein, doses in the range of 1,000 to 2,000 mg per day are commonly used, though the evidence for benefit in this population is less robust than in secondary prevention.

Anti-Inflammatory Effects: Higher Doses for Chronic Inflammation

Omega-3 fatty acids reduce inflammation by competing with arachidonic acid, an omega-6 fatty acid, for incorporation into cell membranes and for access to the enzymes that produce inflammatory eicosanoids. EPA is converted into less inflammatory prostaglandins and leukotrienes compared to those derived from arachidonic acid. DHA is metabolized into specialized pro-resolving mediators, including resolvins and protectins, which actively terminate inflammatory responses rather than simply suppressing them.

Clinical trials examining omega-3s for inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease, and chronic pain have used doses ranging from 2,000 to 4,000 mg of combined EPA and DHA per day. A meta-analysis of studies on rheumatoid arthritis found that doses above 2,600 mg per day were associated with reductions in inflammatory biomarkers such as C-reactive protein and erythrocyte sedimentation rate, as well as decreases in joint pain and stiffness (2024 meta-analysis).

For individuals with elevated inflammatory markers but no diagnosed inflammatory disease, doses in the range of 1,500 to 2,000 mg per day may provide benefit, though individual variation is significant (2023 non-rct experimental). Baseline omega-3 status, dietary omega-6 intake, and genetic factors all influence response. Testing your hs-CRP before and after supplementation provides objective feedback on whether the dose you are taking is producing a measurable anti-inflammatory effect.

Cognitive Function and Brain Health

DHA's role in neuronal membranes

DHA is the predominant omega-3 fatty acid in the brain, where it accounts for roughly 40 percent of the polyunsaturated fatty acids in neuronal membranes. It influences synaptic plasticity, neurotransmitter release, and neuroinflammation. EPA, while present in lower concentrations in the brain, modulates mood and may have antidepressant effects through its influence on inflammatory signaling.

Evidence for cognitive benefits

A systematic review of omega-3 supplementation and cognitive function concluded that daily supplementation with at least 450 mg of combined DHA and EPA makes it more likely to show efficacy on cognition in children and adolescents. In older adults, the evidence is more mixed. Some trials using doses of 1,000 to 2,000 mg per day have shown modest improvements in memory and executive function, particularly in individuals with mild cognitive impairment or low baseline omega-3 status (2024 meta-analysis).

One well-designed trial in older adults with stable coronary artery disease used 3,360 mg of combined EPA and DHA daily and found improved cognitive function at 12 and 30 months compared to placebo, but only in participants who achieved an omega-3 index (the percentage of EPA and DHA in red blood cell membranes) of 4 percent or higher. This suggests that tissue saturation, not just dose, determines response.

Triglyceride Reduction: Prescription-Level Dosing

High-dose omega-3 supplementation is one of the most effective non-statin interventions for lowering triglycerides. Doses of 2,000 to 4,000 mg of EPA per day can reduce triglycerides by 20 to 50 percent, depending on baseline levels. The mechanism involves reduced hepatic synthesis of very-low-density lipoprotein (VLDL) particles, increased clearance of triglyceride-rich lipoproteins, and enhanced fatty acid oxidation.

Prescription omega-3 formulations such as icosapent ethyl (pure EPA) and omega-3-acid ethyl esters (EPA and DHA combined) are FDA-approved for the treatment of severe hypertriglyceridemia, defined as triglycerides above 500 mg/dL. Over-the-counter supplements typically contain 300 to 1,000 mg of combined EPA and DHA per serving, which means achieving prescription-level doses requires taking multiple capsules per day.

For individuals with moderately elevated triglycerides (150 to 500 mg/dL), doses of 1,000 to 2,000 mg per day may produce meaningful reductions, though the effect is dose-dependent. Testing triglycerides before and after supplementation is the only way to know whether the dose you are taking is sufficient.

Form, Timing, and Absorption

Omega-3 supplements come in several chemical forms: natural triglycerides, ethyl esters, re-esterified triglycerides, and phospholipids. Natural triglyceride and re-esterified triglyceride forms are absorbed more efficiently than ethyl esters, particularly when taken without food. Ethyl ester forms require the presence of dietary fat to be hydrolyzed and absorbed, which is why taking them with a meal improves bioavailability.

Taking omega-3s with a meal that contains fat enhances uptake and reduces the likelihood of gastrointestinal side effects such as fishy burps or nausea. Splitting the dose across two meals may improve tolerance at higher intakes. For individuals using high-dose omega-3s for triglyceride reduction, taking the full dose at dinner, when triglyceride synthesis is highest, may offer a slight mechanistic advantage.

Vegan omega-3 supplements derived from algae oil provide DHA and, in some formulations, EPA. Algae-derived omega-3s appear to produce comparable increases in blood EPA and DHA levels to fish oil in bioavailability research, making them a potential alternative for plant-based diets. Typical doses range from 200 to 400 mg of DHA per serving, with some formulations providing up to 300 mg of EPA.

Who Benefits Most and Who Should Be Cautious

Individuals most likely to benefit from omega-3 supplementation include:

• Those with low baseline intake (less than one serving of fatty fish per week).
• People with elevated triglycerides or documented cardiovascular disease.
• Individuals with chronic inflammatory conditions or low omega-3 index.
• Pregnant and lactating women, who have increased DHA requirements to support fetal and infant brain development (typically 200 to 300 mg of DHA per day).

People taking anticoagulant or antiplatelet medications should exercise caution with high-dose omega-3 supplementation, as doses above 3,000 mg per day may increase bleeding risk (2024 meta-analysis). Individuals with fish or shellfish allergies can safely use algae-based omega-3 supplements. Those with impaired fat absorption due to conditions such as celiac disease, inflammatory bowel disease, or pancreatic insufficiency may require higher doses to achieve adequate tissue levels.

Testing Your Omega-3 Status and Tracking Response

The omega-3 index, which measures EPA and DHA as a percentage of total fatty acids in red blood cell membranes, is the most accurate marker of long-term omega-3 status. An index below 4 percent is considered deficient and associated with increased cardiovascular risk. An index of 8 percent or higher is considered optimal.

For individuals supplementing omega-3s for cardiovascular or metabolic goals, tracking triglycerides, hs-CRP, and apolipoprotein B provides objective feedback on whether the dose is producing the intended effect. For those using omega-3s for inflammatory conditions, monitoring symptom severity alongside inflammatory biomarkers offers a more complete picture than either measure alone.

Omega-3 supplementation is not a one-size-fits-all intervention. Knowing where your levels sit and what you are trying to accomplish transforms omega-3 supplementation from a generic wellness habit into a targeted, measurable intervention. Superpower's 100+ biomarker panel includes the lipid, inflammatory, and metabolic markers that determine whether your current omega-3 intake is adequate or whether a higher dose is justified. Testing before you supplement and retesting after gives you the data to dose with precision rather than guesswork.